AstraZeneca beats first-quarter profit estimates, retains 2020 forecast
AstraZeneca on Wednesday beat analysts' estimates for first-quarter profit and reiterated its outlook for 2020, as demand for the company's newer medicines remained steady.
AstraZeneca on Wednesday beat analysts' estimates for first-quarter profit and reiterated its outlook for 2020, as demand for the company's newer medicines remained steady.